Trust Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54K Sell
20
-18
-47% -$1.31K ﹤0.01% 566
2026
Q1
$2.48K Hold
38
﹤0.01% 515
2025
Q4
$3.01K Buy
38
+8
+27% +$613 ﹤0.01% 504
2025
Q3
$2.19K Hold
30
﹤0.01% 364
2025
Q2
$2.27K Hold
30
﹤0.01% 375
2025
Q1
$2.28K Hold
30
﹤0.01% 399
2024
Q4
$1.98K Sell
30
-21
-41% -$1.47K ﹤0.01% 388
2024
Q3
$3.56K Sell
51
-53
-51% -$3.19K ﹤0.01% 331
2024
Q2
$5.5K Buy
+104
New +$6.31K ﹤0.01% 298

Other funds holding SOLV

Trust Company's SOLV Position: Q2 2026 in Review

Trust Company reduced its Solventum (SOLV) stake by 47% in Q2 2026, selling an estimated $1.31K and leaving 20 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Trust Company first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.5K in Q2 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Trust Company held 20 shares of Solventum worth $1.54K as of Q2 2026.
  • Trust Company sold 18 Solventum shares in Q2 2026, an estimated $1.31K.
  • Solventum made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #566 holding.
  • Trust Company first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Trust Company's Solventum position peaked at $5.5K in Q2 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.